Boston Scientific Corporation
Clinical trials sponsored by Boston Scientific Corporation, explained in plain language.
-
New hope for stroke prevention: device helps AFib patients who Can't use blood thinners
Disease control CompletedThis study tested the WATCHMAN device, a small implant placed in the heart to close off a part called the left atrial appendage, where clots often form in people with atrial fibrillation (AFib). The goal was to reduce stroke risk in 481 patients with AFib who could not take stand…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 26, 2026 03:25 UTC
-
Gel cushion shields rectum during prostate radiation in small study
Disease control CompletedThis study tested a gel called SpaceOAR that is injected between the prostate and rectum before radiation therapy for prostate cancer. The gel creates a temporary space to help protect the rectum from radiation damage. Fifteen men with early-stage prostate cancer took part, and t…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 26, 2026 03:24 UTC
-
Heart device healing scrutinized by advanced scans
Disease control CompletedThis study looked at how well the WATCHMAN FLX Pro device, used to close a small pouch in the heart to prevent strokes in people with atrial fibrillation, gets covered by the body's own tissue after implantation. Researchers used CT scans and echocardiograms to check for any abno…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 26, 2026 03:18 UTC
-
New device offers hope for men with leaky bladder after prostate surgery
Disease control CompletedThis study tested a device called the AMS 800 Artificial Urinary Sphincter in 145 men who had stress urinary incontinence (leaking urine) after prostate surgery. The goal was to see if the device could reduce urine leakage by at least half after one year. The device is surgically…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
New stent study shows promise for leg artery disease patients
Disease control CompletedThis study looked at how well the ELUVIA drug-coated stent works in real-world patients with blocked arteries in the thigh or knee area. About 291 adults received the stent and were followed for two years. Researchers measured changes in quality of life and walking ability to see…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
Device may replace daily blood thinners for some AF patients
Disease control CompletedThis study tested whether closing off a small heart pouch (left atrial appendage) with the WATCHMAN FLX device is a safe and effective alternative to long-term blood thinners in people with atrial fibrillation who already had a catheter ablation. About 1,600 high-risk participant…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New device shows promise in reducing stroke risk for heart patients
Disease control CompletedThis study tested the WATCHMAN FLX Pro device in 949 people with atrial fibrillation (an irregular heartbeat) to see how well it prevents strokes. The device is implanted to close off a part of the heart where clots can form. Researchers measured safety and effectiveness in real-…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 20, 2026 11:58 UTC
-
New balloon treatment shows promise for leg artery blockages
Disease control CompletedThis study tested a special balloon coated with a drug to open blocked arteries in the leg. 123 patients in China received this treatment. The goal was to see if the balloon is safe and works well to improve blood flow and keep arteries open for at least a year.
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New heart zapping technique shows promise for stubborn irregular heartbeat
Disease control CompletedThis study tested a new procedure called pulsed field ablation (using the FARAPULSE system) in 669 people with persistent atrial fibrillation (a type of irregular heartbeat) that did not get better with medication. The goal was to see if the procedure is safe and can restore a no…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New freezing technique shows promise for heart rhythm disorder
Disease control CompletedThis study tested a device that freezes small areas of heart tissue to stop irregular heartbeats (atrial fibrillation). 295 patients were treated and followed for a year to see if the procedure was safe and prevented heart rhythm problems. The goal is to control the condition, no…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
New heart ablation tech shows promise for AFib patients
Disease control CompletedThis study tested a special mapping system and catheters to treat a type of irregular heartbeat called paroxysmal atrial fibrillation (AFib). 415 people who had never had this procedure before took part. The goal was to see if the system could safely and effectively stop AFib epi…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
Heart rhythm study tracks AF progression years after ablation
Disease control CompletedThis study followed 364 people with paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes) who had already received ablation treatment in an earlier trial. Researchers compared two ablation methods—pulsed field ablation and thermal ablation—to see how …
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
New embolic device shows promise in stopping tumor bleeding
Disease control CompletedThis study looked at how well and how safely the Obsidio device blocks blood vessels to control bleeding from hypervascular tumors. It involved 125 patients in the U.S. who were treated with Obsidio. The main goals were to see if the device successfully blocked the target vessels…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New data on pain relief: radiofrequency ablation shows promise
Symptom relief CompletedThis study tracked 298 people with chronic pain who received radiofrequency ablation, a procedure that uses heat to target pain nerves. The goal was to see how much their pain improved in the real world. Participants rated their overall change using a standard scale, from 'very m…
Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 26, 2026 03:27 UTC
-
Balloon bypass offers hope for eating again in stomach cancer
Symptom relief CompletedThis study tested a new, less invasive procedure to open a blocked stomach caused by advanced cancer. 51 people who could not eat due to the blockage received the treatment. The goal was to help them eat solid food again without serious complications.
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 26, 2026 03:10 UTC
-
New heart mapping tech shows promise in AFib procedure
Symptom relief CompletedThis study tested a new feature called FARAVIEW on a heart mapping system used with a special catheter to treat atrial fibrillation (an irregular heartbeat). Fifty adults with symptomatic AFib that didn't respond to medication took part. The goal was to see how well doctors could…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 26, 2026 03:10 UTC
-
Laser showdown: breaking vs dusting kidney stones
Symptom relief CompletedThis study tested two ways of using a laser to remove kidney stones during a scope procedure. Twenty adults with stones between 0.8 and 2 cm took part. One group had stones broken into pieces, the other turned into dust. The goal was to see which method clears stones faster and w…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 22, 2026 13:53 UTC
-
New brain pacemaker programming shows promise for Parkinson's
Symptom relief CompletedThis study tested a new way of programming deep brain stimulation (DBS) in 15 people with Parkinson's disease. The goal was to see if this different programming could improve their quality of life. Participants already had DBS devices implanted and were monitored for changes in s…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 22, 2026 13:51 UTC
-
New laser zaps away prostate problems in minutes
Symptom relief CompletedThis study tested a special laser device to treat an enlarged prostate (BPH) in 20 men who were already scheduled for surgery. The laser was used to vaporize extra prostate tissue, and the researchers measured how long it took and how much tissue was removed. They also tracked si…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 22, 2026 13:50 UTC
-
Heart stent study tracks Real-World results in thousands of patients
Knowledge-focused CompletedThis study looked at how well a specific heart stent (PROMUS PREMIER) works in everyday medical practice in China. Over 2,000 patients with coronary artery disease were followed for 12 months to track serious heart events like heart attacks or the need for repeat procedures. The …
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC
-
Stent safety check: global registry tracks Real-World results
Knowledge-focused CompletedThis study collected information from 379 people who received a Boston Scientific ureteral stent to treat a blocked ureter. Researchers tracked how often the stent successfully drained urine without needing another procedure, and recorded any serious side effects. The goal was to…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 18, 2026 12:03 UTC
-
Heart device data collected from 500 chinese patients
Knowledge-focused CompletedThis study gathered real-world information on how well a special balloon catheter (Agent DCB) works for opening blocked heart arteries in Chinese patients. Researchers followed 500 adults for 12 months after their procedure to track heart-related events like heart attacks or the …
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
Chronic pain patients share real results in new study
Knowledge-focused CompletedThis study gathered real-world information from 73 adults with chronic pain who were using or planning to use an approved medical device for pain relief. Researchers tracked changes in pain levels and other patient-reported outcomes to understand how these treatments work in ever…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC